ARTICLE SUMMARY:
Ischemic stroke was once referred to as the “number one cause of death” for a medical device company. But next-generation stent retriever devices and other clot removal techniques have shown promise in recent clinical trials, and that is good news, both for patients and the leading device companies in the space, as well as for start-ups hoping to address the limitations of current therapies.
The field of ischemic stroke intervention is on the verge of a paradigm shift.
